Scientists have found that statins — commonly used cholesterol-lowering drugs — may block a pathway that leads to the development of cancer in the context of chronic inflammation.
Scientists have found that statins — commonly used cholesterol-lowering drugs — may block a pathway that leads to the development of cancer in the context of chronic inflammation.